Provenance du réseau au premier degré de Jonathan Miller
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 18 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jonathan Miller via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman Founder | |
Diacrin, Inc. (Delaware)
 Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Diacrin, Inc. develops human cell transplant therapeutic products. The company is headquartered in Wilmington, DE. | Medical Specialties | Director/Board Member Director/Board Member | |
LeukoSite, Inc.
 LeukoSite, Inc. Pharmaceuticals: MajorHealth Technology LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA. | Pharmaceuticals: Major | Chief Operating Officer Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
Wedbush Securities, Inc.
 Wedbush Securities, Inc. Investment Banks/BrokersFinance Wedbush Securities, Inc. is a full-service investment bank and brokerage firm headquartered in Los Angeles, California. The firm was founded in 1955 as Wedbush Morgan Securities, Inc. They are a subsidiary of Wedbush Financial Services LLC, which is owned by Wedbush, Inc. Wedbush Securities provides a wide range of securities brokerage, wealth management, and investment banking services to private and institutional clients. Their research focuses on providing coverage of small and mid-sized companies in the following industries: (1) consumer products and services (2) technology (3) entertainment and media (4) life sciences and (5) industrial growth and clean technology. | Investment Banks/Brokers | Director of Research - Equity | |
NitroMed, Inc.
 NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Founder Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal General Counsel | |
Potentia Pharmaceuticals, Inc.
 Potentia Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Potentia Pharmaceuticals, Inc. operates as a biotechnology company. It focuses on the development of novel therapeutics and drug delivery technologies to address chronic inflammatory diseases. The company was founded by Cedric Francois, David Darst, Alec Machiels and Pascal Deschatelets in 2001 and is headquartered in Crestwood, KY. | Pharmaceuticals: Major | Director/Board Member | |
FoldRx Pharmaceuticals LLC
 FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
ActivBiotics, Inc.
 ActivBiotics, Inc. BiotechnologyHealth Technology ActivBiotics, Inc. discovers and develops pharmaceutical drugs. It provides discovery, development, and commercialization of therapies for the treatment of vascular disease, inflammation, and other high-value chronic and infectious diseases. The company was founded in 1996 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member | |
| TETRALOGIC PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
Adheron Therapeutics, Inc.
 Adheron Therapeutics, Inc. BiotechnologyHealth Technology Adheron Therapeutics, Inc. discovers and develops therapeutic drugs. The firm offers Cadherin-11 antagonists for the treatment of rheumatoid arthritis and fibrotic diseases including pulmonary fibrosis and skin fibrosis. The company was founded by David Lee, Michael B. Brenner, and David L. Castaldi in 2006 and is headquartered in Berkeley, CA. | Biotechnology | Director/Board Member President Director/Board Member | |
Galleon Pharmaceuticals, Inc.
 Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galleon Pharmaceuticals, Inc. develops and manufactures medicines for breathing-control conditions. Its product pipeline addresses the needs of both acute and chronic care patients. The firm's GAL-021 product is a small molecule for intravenous administration designed to support respiratory drive in surgical and critical care patients, and in particular those high risk patients with sleep apnea who are undergoing surgery. The company was founded by James C. Mannion in 2003 and is headquartered in Horsham, PA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| APELLIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Layerbio, Inc.
 Layerbio, Inc. Miscellaneous Commercial ServicesCommercial Services Layerbio, Inc. develops bio erodible sustained-release technology for use in standard intraocular lens in cataract surgery. The private company is based in Lexington, MA. The company was founded in 2013 by Kenneth J. Mandell, Paula Hammond. Kenneth J. Mandell has been the CEO since 2013. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
HealthCare Ventures LLC
 HealthCare Ventures LLC Investment ManagersFinance HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor Private Equity Investor | |
| University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree | |
Tekla Capital Management LLC
 Tekla Capital Management LLC Investment ManagersFinance Tekla Capital Management LLC is an independent, SEC-registered investment advisor headquartered in Boston, Massachusetts. Formerly known as Hambrecht & Quist Capital Management LLC, the firm serves as an investment adviser for four closed-end funds – Tekla Healthcare Investors, Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund and Tekla World Healthcare Fund. | Investment Managers | Analyst-Equity | |
| Boston University | College/University | Corporate Officer/Principal Masters Business Admin Doctorate Degree | |
| The University of Manchester | College/University | Masters Business Admin Undergraduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
| New York University | College/University | Graduate Degree | |
Senseonics, Inc.
 Senseonics, Inc. Electronic ComponentsElectronic Technology Senseonics, Inc. develops transformative glucose monitoring products. It develops Senseonics continuous glucose monitoring system, an implantable continuous glucose monitoring system, which includes a miniaturized sensor and receiver that is inserted into the subcutaneous space under the skin to wirelessly transmit glucose levels to an external receiver. The company was founded by Michael James Barrett and Arthur E. Colvin in 1996 and is headquartered in Germantown, MD. | Electronic Components | Director/Board Member Director/Board Member | |
Prevent Cancer Foundation
 Prevent Cancer Foundation Hospital/Nursing ManagementHealth Services Prevent Cancer Foundation provides cancer prevention services. The firm offers treatment for colorectal, prostate, breast, skin and testicular cancers. It also provides early detection research, education and community outreach programs across the country. The company was founded in 1985 and is headquartered in Alexandria, VA. | Hospital/Nursing Management | Director/Board Member | |
Merlin Nexus
 Merlin Nexus Investment ManagersFinance Merlin Nexus is a private equity firm founded in 2001. The firm headquartered in New York. | Investment Managers | Private Equity Analyst | |
Healthcare Ventures VII LP
 Healthcare Ventures VII LP Investment ManagersFinance HealthCare Ventures VII LP seeks investment opportunities in life science companies located in the US with an annual revenues ranging from $50 - $100 million. The fund targets companies operating in the fields of cancer therapy, infectious diseases, cardiovascular diseases, central nervous system disorders, immunotherapy, novel manufacturing technologies and novel lab scale instruments & reagents. It provides financing in the form of equity and debt convertible to equity for early and later stage capital requirements with an investment size of $1,000,000 - $20,000,000. It also makes investments in both private and public companies. | Investment Managers | Corporate Officer/Principal | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | President President | |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Medical Specialties | Corporate Officer/Principal | |
| Healthcare Pharmaceuticals, Inc. (Utah) | Director/Board Member Director/Board Member | ||
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| VA Medical Center (District of Columbia) | General Government | Corporate Officer/Principal | |
Vaxxas Pty Ltd.
 Vaxxas Pty Ltd. Medical SpecialtiesHealth Technology Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia. | Medical Specialties | Director/Board Member | |
| Cornell University Council | Corporate Officer/Principal | ||
| The University of Michigan Law School | College/University | Graduate Degree | |
| Codfish Investments LLC | Corporate Officer/Principal | ||
| EIGER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chairman | |
Healthcare Strategic Partners, LLC
 Healthcare Strategic Partners, LLC Medical/Nursing ServicesHealth Services Part of HealthCare Ventures LLC, Healthcare Strategic Partners, LLC is an American company that provides healthcare services. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Nutcracker Therapeutics, Inc.
 Nutcracker Therapeutics, Inc. Information Technology ServicesTechnology Services Nutcracker Therapeutics, Inc. provides Biotechnology services. It offers push button operation, rapid cycle times and delivery vehicles. The company was founded by Igor Khandros and Benjamin Eldridge in 2018 and is headquartered in Emeryville, CA. | Information Technology Services | Director/Board Member | |
| Healthcare Partners IX LLC | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 49 |
| Royaume-Uni | 2 |
| Australie | 2 |
Sectorielle
| Health Technology | 27 |
| Consumer Services | 8 |
| Finance | 6 |
| Health Services | 4 |
| Commercial Services | 3 |
Opérationnelle
| Director/Board Member | 151 |
| Corporate Officer/Principal | 60 |
| President | 28 |
| Independent Dir/Board Member | 28 |
| Chairman | 20 |
Relations les plus connectées
| Insiders | |
|---|---|
| Augustine Lawlor | 43 |
| James Cavanaugh | 38 |
| Chris Mirabelli | 29 |
| Doug Onsi | 25 |
| Joseph Loscalzo | 25 |
| Patricia Martin | 21 |
| Thomas Dietz | 21 |
| John W. Littlechild | 21 |
| Monica Bertagnolli | 14 |
| Nissim Mashiach | 11 |
| William Li | 10 |
| Chris Richard | 9 |
| Richard Schilsky | 9 |
| Mark O’Mahony | 8 |
| Christine M. Granfield | 5 |
- Bourse
- Insiders
- Jonathan Miller
- Connexions Sociétés
